The Institute of Empirical Health Economics


The Institute of Empirical Health Economics is an extra-universitary research unit for the areas of medical and pharmaceutical research. We have been working successfully for national and international companies for more than ten years. The assignments involved aspects of medicine, clinical research, marketing and controlling.

You will find a highly qualified and experienced team of physicians, scientist and economists to assist you. Altogether our team consists of 17 members and our profile is completed with our own biometry department. We combine experience and knowledge in marketing and research which enable us to provide our clients with optimal service. All in all we have realized more than 500 projects.

The interdisciplinary nature of health economics and the comprehensiveness and versatility of our service spectrum are illustrated when you consider the different areas involved in the health care sector. These include the pharmaceutical industry, medical technology, producers of remedies, hospitals, health insurance companies, ministries and political health institutions, as well as chambers and councils of physicians and pharmacists, and organisations for professional medical assistants and care takers.

  • Diagnostics Industry
  • Medical technology
  • Pharmaceutical Industry
  • Health Insurance Funds
  • Health Politics
  • Reimbursment Institutions
  • Associations
  • Professional Societies
  • Ministeries


  • Benefit Assessment /
    Reimbursement /
  • Conceptions / Strategies
  • Added Value / Value Story
  • Second Opinion (Proofreading)
  • Reimbursement Opinion
  • Publications
  • Lectures

Health Care and

  • Clinical Studies
  • Observational Studies
  • Case-Control Studies
  • Epidemiological Studies
  • Register
  • Health Technology Assessment
  • Modelling
  • Reimbursement Dossiers
  • Benefit Dossiers/ AMNOG
  • Secondary Data Analyses

Negotiation Management

  • Advisory Boards
  • Steering Committees
  • Delphi Panels
  • Conjoint Measurement


  • Advisory Boards
  • Assessment Evaluation of IV contracts and DMP‘s
  • Budget Impat Analysis
  • Clinical Studies (RCT’s)
  • Consulting AMNOG
  • Cost-Effectiveness-Models
  • Epidemiological Reviews and Studies
  • Health Services Research
  • HTA
  • Non-Interventional Studies
  • Observational Studies
  • Pharmacoeconomic Studies
  • Risk sharing and Tender
  • Systematic Literature Review
  • Value Dossier AMNOG